CAT No: CP00907
CAS No:29022-11-5
Synonyms/Alias:Fmoc-Gly-OH;Fmoc-glycine;29022-11-5;Fmoc-DL-Glycine;N-9-Fmoc-L-glycine;N-[(9H-Fluoren-9-ylmethoxy)carbonyl]glycine;N-Fmoc-glycine;N-alpha-FMOC-GLYCINE;N-(9-Fluorenylmethoxycarbonyl)glycine;SBB067133;9-FLUORENYLMETHOXYCARBONYL-GLYCINE;n-[(9h-fluoren-9-ylmethoxy)carbonyl]glycin;N-(9-FLUORENYLMETHOXYCARBONYL)-GLYCINE;2-(9H-fluoren-9-ylmethoxycarbonylamino)aceticacid;{[(9H-fluoren-9-ylmethoxy)carbonyl]amino}aceticacid;2-{[(9H-fluoren-9-ylmethoxy)carbonyl]amino}aceticacid;(9H-FLUOREN-9-YLMETHOXYCARBONYLAMINO)-ACETICACID;2-((((9H-FLUOREN-9-YL)METHOXY)CARBONYL)AMINO)ACETICACID;N-((9H-Fluoren-9-ylmethoxy)carbonyl)glycine;2-[(fluoren-9-ylmethoxy)carbonylamino]aceticacid;2-({[(9H-FLUOREN-9-YL)METHOXY]CARBONYL}AMINO)ACETICACID;N-Fmocglycine;N-(Fmoc)glycine;NSC334288;FMOC-GLY
1. Urinary Metabolites Associated with Blood Pressure on a Low-or High-Sodium Die
4. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.